4.3 Review

Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review

期刊

STEM CELL REVIEWS AND REPORTS
卷 18, 期 1, 页码 56-76

出版社

SPRINGER
DOI: 10.1007/s12015-021-10285-w

关键词

Dipeptidyl peptidase 4; Mesenchymal stem-cells; Dipeptidyl peptidase-4 inhibitor; Dipeptidyl peptidase-4 substrate; Wound healing; Regenerative medicine

资金

  1. Ministerio de Economia y Competitividad (MINECO), Spain
  2. European Union (EU)
  3. CIBER Fragilidad y Envejecimiento Saludable (CIBERFES) of Instituto de Salud Carlos III (ISCIII)
  4. [PI15/01857]
  5. [PI18/01659]

向作者/读者索取更多资源

DPP4 and its inhibitors are important for diabetes treatment, but their potential effects in regenerative medicine, including on MSC and their differentiation, immunomodulation, and mobilization capacities, should be further explored.
Dipeptidyl peptidase IV (DPP4) is a ubiquitous protease that can be found in membrane-anchored or soluble form. Incretins are one of the main DPP4 substrates. These hormones regulate glucose levels, by stimulating insulin secretion and decreasing glucagon production. Because DPP4 levels are high in diabetes, DPP4 inhibitor (DPP4i) drugs derived from gliptin are widespread used as hypoglycemic agents for its treatment. However, as DPP4 recognizes other substrates such as chemokines, growth factors and neuropeptides, pleiotropic effects have been observed in patients treated with DPP4i. Several of these substrates are part of the stem-cell niche. Thus, they may affect different physiological aspects of mesenchymal stem-cells (MSC). They include viability, differentiation, mobilization and immune response. MSC are involved in tissue homeostasis and regeneration under both physiological and pathological conditions. Therefore, such cells and their secretomes have a high clinical potential in regenerative medicine. In this context, DPP4 activity may modulate different aspects of MSC regenerative capacity. Therefore, the aim of this review is to analyze the effect of different DPP4 substrates on MSC. Likewise, how the regulation of DPP4 activity by DPP4i can be applied in regenerative medicine. That includes treatment of cardiovascular and bone pathologies, cutaneous ulcers, organ transplantation and pancreatic beta-cell regeneration, among others. Thus, DPP4i has an important clinical potential as a complement to therapeutic strategies in regenerative medicine. They involve enhancing the differentiation, immunomodulation and mobilization capacity of MSC for regenerative purposes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据